CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights
| CNTG Stock | USD 0.09 0.01 16.88% |
Roughly 53% of Centogene's stockholders are presently thinking to get in. The analysis of overall sentiment of trading Centogene B V stock suggests that some investors are interested at this time. The current market sentiment, together with Centogene's historical and current headlines, can help investors time the market. In addition, many technical investors use Centogene B V stock news signals to limit their universe of possible portfolio assets.
Centogene |
Reported Full Year 2023 total revenues of 2 percent growth at 48.5 millionSecured approximately USD 20 million strengthening cash position and expanding...
Read at globenewswire.com
 |
Centogene Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Centogene can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Centogene Fundamental Analysis
We analyze Centogene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Centogene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Centogene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Centogene is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Centogene B V Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Centogene stock to make a market-neutral strategy. Peer analysis of Centogene could also be used in its relative valuation, which is a method of valuing Centogene by comparing valuation metrics with similar companies.
Peers
Centogene Related Equities
| MYNZ | Mainz Biomed | 13.04 | ||||
| NOTV | Inotiv | 10.97 | ||||
| STRR | Star Equity | 8.57 | ||||
| ACRS | Aclaris Therapeutics | 5.23 | ||||
| SERA | Sera Prognostics | 2.80 | ||||
| SHC | Sotera Health | 1.16 | ||||
| MDXH | MDxHealth | 1.03 | ||||
| FONR | Fonar | 0.36 | ||||
| CSTL | Castle Biosciences | 0.43 | ||||
| BDSX | Biodesix | 0.69 | ||||
| PRE | Prenetics Global | 1.56 | ||||
| STRRP | Star Equity | 1.77 | ||||
| XGN | Exagen | 2.54 |
Complementary Tools for Centogene Stock analysis
When running Centogene's price analysis, check to measure Centogene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Centogene is operating at the current time. Most of Centogene's value examination focuses on studying past and present price action to predict the probability of Centogene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Centogene's price. Additionally, you may evaluate how the addition of Centogene to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |